Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective

The coronavirus SARS-CoV-2, which causes Coronavirus disease 2019 (COVID-19), has infected more than 100 million people globally and caused over 2.5 million deaths in just over one year since its discovery in Wuhan, China in December 2019. The pandemic has evoked widespread collateral damage to soci...

Descripción completa

Detalles Bibliográficos
Autores principales: Funk, Colin D., Laferrière, Craig, Ardakani, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998902/
https://www.ncbi.nlm.nih.gov/pubmed/33807839
http://dx.doi.org/10.3390/v13030418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998902/
https://www.ncbi.nlm.nih.gov/pubmed/33807839
http://dx.doi.org/10.3390/v13030418

Ejemplares similares